Breaking News

Euro-Area Economy Shows Signs of Weakening as Surveys Miss Forecasts
Tweet TWEET

Consent for Amendments, Participation in Investor Conferences, and Stock Price Updates - Research Report on Perrigo, Waters,

Consent for Amendments, Participation in Investor Conferences, and Stock Price
Updates - Research Report on Perrigo, Waters, HealthSouth, Insulet and Globus

PR Newswire

NEW YORK, November 26, 2013

NEW YORK, November 26, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Perrigo
Company (NYSE:PRGO),

Waters Corporation (NYSE:WAT), HealthSouth Corp (NYSE:HLS), Insulet
Corporation (NASDAQ:PODD) and Globus Medical Inc (NYSE:GMED). Today's readers
may access these reports free of charge - including full price targets,
industry analysis and analyst ratings - via the links below.

Perrigo Company Research Report

On November 21, 2013, Perrigo Company (Perrigo) announced that it has received
the requisite consents to amend the indenture governing its previously
announced tender offer and consent solicitation for its 2.950% Notes due 2023.
Perrigo stated that the Consent Solicitation expired at 5:00 p.m. New York
City time on November 19, 2013, and at the consent deadline, 95.27% of the
outstanding Notes had been validly tendered and not withdrawn. As a result,
the requisite number of consents has been received with respect to the Consent
Solicitation. Accordingly, the Company and Wells Fargo Bank, National
Association, the trustee under the indenture governing the Notes, entered into
a supplemental indenture, which would amend the indenture under which the
Notes were issued. The Full Research Report on Perrigo Company - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/4168_PRGO

Waters Corporation Research Report

On November 21, 2013, Waters Corporation's (Waters) stock rose 0.98% to end
the day's trading session at $101.38. Shares of Waters have increased 0.13%
over the previous three trading sessions, while the Dow Jones Industrial
Average Index rose 0.21% during the same period. The Full Research Report on
Waters Corporation - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/2fff_WAT

HealthSouth Corp Research Report

On November 21, 2013, shares of HealthSouth Corp (HealthSouth) rose 0.15% to
end trading session at $34.31. Over the previous three trading sessions,
HealthSouth's shares dipped 0.78%, compared to the Dow Jones Industrial
Average Index, which rose 0.21% during the same period. The Full Research
Report on HealthSouth Corp - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/9080_HLS

Insulet Corporation Research Report

On November 21, 2013, Insulet Corporation (Insulet) announced that it will
participate in two investor conferences in December 2013. According to the
Company, its management is scheduled to make a presentation at the Piper
Jaffray 25th Annual Healthcare Conference, to be held at New York Palace Hotel
in New York City, on December 3, 2013 at 3:30 p.m. ET. Additionally, the
Company will also take part in the Oppenheimer 24th Annual Healthcare
Conference, to be held at Crowne Plaza Hotel in New York City, on December 10,
2013 at 10:55 a.m. ET. Insulet informed that material information and audio
webcasts for these presentations will be available at the investor's section
of Insulet's website, wherein a replay of each webcast will also be available
for 10 days after the initial presentation. The Full Research Report on
Insulet Corporation - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/75e4_PODD

Globus Medical Inc Research Report

On November 21, 2013, Globus Medical Inc's (Globus) shares closed at $18.54,
indicating a rise of 0.98%. Over the previous three trading sessions, shares
of Globus increased 1.09%, while the Dow Jones Industrial Average Index
increased 0.21% during the same period. The Full Research Report on Globus
Medical Inc - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/5898_GMED

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to making mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.analystscorner.com/

SOURCE Analysts' Corner

Contact: Joe Thomas, +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.